DNDi
Non-Profit & Charitable Organizations · New York, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
40 Rector St Fl 16, New York City, New Y...Phone Number
(646) 215-7076Website
www.dndi.orgRevenue
$17.9 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About DNDi
DNDi is an international non-profit organization dedicated to developing safe, effective, and affordable treatments for neglected diseases affecting patients globally. Since its inception in 2003, DNDi has successfully developed 14 treatments for 6 deadly diseases, significantly improving health outcomes for millions. The organization collaborates with partners in low- and middle-income countries to foster innovation and advocate for equitable access to medicines. DNDi's work encompasses research and development, clinical trials, and policy advocacy to address the needs of neglected patients.Explore more
DNDi Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is DNDi your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check out if DNDi is spiking on competitors!
Check if DNDi has recently received funding, and reach out quickly before it becomes old news!
Click to see if DNDi had a recent Job posting/layoffs
DNDi, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when DNDi launches new products
Earning: See what the market has to say on DNDi recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at DNDi
Funding: Get notified immidiatlly once DNDi has new funding data
Recommended Actions
Reach out to Masked Content who joined DNDi as Masked Content
Find more new buyers
Compare Similar Companies to DNDi
Compare insights from companies similar to DNDi, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
DNDi
$17.9M
201-500
Private
-
2003
FM
Fabrice MulanguRegional Head of Operations (Central & West Africa)
$38.6M
201-500
Private
<$5M
2003
Anna FeldmanClinical Trial Support Specialist & Chief Revenue Officer, Services
Company Profile Activity
Activity Insights
DNDi is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
DNDi is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about DNDi.
DNDi Tech Stack
A closer look at the technologies used by DNDi
See more technologies
Most Recent Scoops
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Open Position
Open Position
DNDi News & Media
Press Release: Acoziborole: Investigational single-dose oral treatment raises hope for elimination of sleeping sickness in Africa
Acoziborole: Investigational single-dose oral treatment raises hope for elimination of sleeping sickness in AfricaCipla and DNDi launch child-friendly 4-in-1 antiretroviral treatment for young children living with HIV in South Africa
CAPE TOWN, South Africa and MUMBAI, India , June 14, 2022 /PRNewswire/ -- The South African Health Products Regulatory Authority (SAHPRA) has approved a sweet-tasting, heat-stable, '4-in-1' fixed-dose combination of four antiretroviral (ARV) treatments composed of abacavir, lamivudine,...DNDi and BenevolentAI collaborate to accelerate life-saving drug discovery research in dengue
- The collaboration will use AI to identify potential biological targets and therapies that could be repurposed for dengue to prevent disease progression - Dengue is a climate-sensitive neglected disease and one of the top ten threats to global public health worldwide, with an estimated...Ajinomoto Bio-Pharma Services and DNDi Partner to Develop Critical Immunomodulator for Cutaneous Leishmaniasis Therapeutic
OSAKA, Japan, Sept. 29, 2020 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce a strategic supply partnership with the Drugs for Neglected Disease Initiative...
Read more news
Top Non-Profit & Charitable Organizations Companies
See more top companies
Frequently Asked Questions Regarding DNDi
Sign Up For FreeTo access detailed company insights
DNDi is an international non-profit organization dedicated to developing safe, effective, and affordable treatments for neglected diseases affecting patients globally. Since its inception in 2003, DNDi has successfully developed 14 treatments for 6 deadly diseases, significantly improving health outcomes for millions. The organization collaborates... Read More
